Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases
Background: Therapies for metabolic diseases are numerous, yet improving insulin sensitivity beyond that induced by weight loss remains challenging. Therefore, search continues for novel treatment candidates that can stimulate insulin sensitivity and increase weight loss efficacy in combination with...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2021-04-01
|
| Schriftenreihe: | Molecular Metabolism |
| Schlagworte: | |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S2212877820301836 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|